Homozygous Familial Hypercholesterolaemia International Clinical Collaboration (HICC) registry: levelling up access to treatment urgently needed
European Atherosclerosis Society Consensus Panel: New Statement on Triglyceride-Rich Lipoproteins and their Remnants
EAS Task Force gives practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients
Latest European Atherosclerosis Society statement reaffirms commitment to the UN Sustainable Development Goals 2030 Agenda